117 related articles for article (PubMed ID: 8991348)
1. Evaluation of paromomycin sulphate topical ointment as effective therapeutic agent in cutaneous leishmaniasis.
Sahibzada NJ; Tareen AK; Khursheed T; Darr N
J Pak Med Assoc; 1996 Mar; 46(3):53-5. PubMed ID: 8991348
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran.
Iraji F; Sadeghinia A
Ann Trop Med Parasitol; 2005 Jan; 99(1):3-9. PubMed ID: 15701249
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cutaneous leishmaniasis by photodynamic therapy.
Gardlo K; Horska Z; Enk CD; Rauch L; Megahed M; Ruzicka T; Fritsch C
J Am Acad Dermatol; 2003 Jun; 48(6):893-6. PubMed ID: 12789181
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.
Asilian A; Davami M
Clin Exp Dermatol; 2006 Sep; 31(5):634-7. PubMed ID: 16780497
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran.
Asilian A; Jalayer T; Nilforooshzadeh M; Ghassemi RL; Peto R; Wayling S; Olliaro P; Modabber F
Bull World Health Organ; 2003; 81(5):353-9. PubMed ID: 12856053
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.
Ozgoztasi O; Baydar I
Int J Dermatol; 1997 Jan; 36(1):61-3. PubMed ID: 9071622
[TBL] [Abstract][Full Text] [Related]
7. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.
Neal RA; Murphy AG; Olliaro P; Croft SL
Trans R Soc Trop Med Hyg; 1994; 88(2):223-5. PubMed ID: 8036682
[TBL] [Abstract][Full Text] [Related]
8. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
Ben Salah A; Ben Messaoud N; Guedri E; Zaatour A; Ben Alaya N; Bettaieb J; Gharbi A; Belhadj Hamida N; Boukthir A; Chlif S; Abdelhamid K; El Ahmadi Z; Louzir H; Mokni M; Morizot G; Buffet P; Smith PL; Kopydlowski KM; Kreishman-Deitrick M; Smith KS; Nielsen CJ; Ullman DR; Norwood JA; Thorne GD; McCarthy WF; Adams RC; Rice RM; Tang D; Berman J; Ransom J; Magill AJ; Grogl M
N Engl J Med; 2013 Feb; 368(6):524-32. PubMed ID: 23388004
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.
Asilian A; Jalayer T; Whitworth JA; Ghasemi RL; Nilforooshzadeh M; Olliaro P
Am J Trop Med Hyg; 1995 Dec; 53(6):648-51. PubMed ID: 8561269
[TBL] [Abstract][Full Text] [Related]
10. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
Weinrauch L; Cawich F; Craig P; Sosa JX; el-On J
J Am Acad Dermatol; 1993 Sep; 29(3):443-6. PubMed ID: 8349861
[TBL] [Abstract][Full Text] [Related]
11. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
Shazad B; Abbaszadeh B; Khamesipour A
Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817
[TBL] [Abstract][Full Text] [Related]
12. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
Arana BA; Mendoza CE; Rizzo NR; Kroeger A
Am J Trop Med Hyg; 2001 Nov; 65(5):466-70. PubMed ID: 11716099
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.
Ben Salah A; Zakraoui H; Zaatour A; Ftaiti A; Zaafouri B; Garraoui A; Olliaro PL; Dellagi K; Ben Ismail R
Am J Trop Med Hyg; 1995 Aug; 53(2):162-6. PubMed ID: 7677218
[TBL] [Abstract][Full Text] [Related]
14. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Moosavi Z; Nakhli A; Rassaii S
Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
[No Abstract] [Full Text] [Related]
15. [Topical treatment of persistent cutaneous leishmaniasis with paromomycin].
Flaig MJ; Rupec J; Ruzicka T; Rupec RA
Hautarzt; 2007 Aug; 58(8):689-90, 692. PubMed ID: 17676349
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
[TBL] [Abstract][Full Text] [Related]
17. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
Aguiar MG; Silva DL; Nunan FA; Nunan EA; Fernandes AP; Ferreira LA
J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
[TBL] [Abstract][Full Text] [Related]
18. Treatment of 'Old World' cutaneous leishmaniasis with aminosidine ointment: results of an open study in London.
Bryceson AD; Murphy A; Moody AH
Trans R Soc Trop Med Hyg; 1994; 88(2):226-8. PubMed ID: 8036683
[TBL] [Abstract][Full Text] [Related]
19. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
Grogl M; Schuster BG; Ellis WY; Berman JD
J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
[TBL] [Abstract][Full Text] [Related]
20. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study.
el-On J; Halevy S; Grunwald MH; Weinrauch L
J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):227-31. PubMed ID: 1430361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]